Transferrin-antibody fusion proteins are effective in brain targeting
about
Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier.Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endotheliumCombinatorial approaches for the identification of brain drug delivery targets.Emerging Applications of Therapeutic Ultrasound in Neuro-oncology: Moving Beyond Tumor Ablation.Human growth hormone-transferrin fusion protein for oral delivery in hypophysectomized rats.Emerging mass spectrometry-based approaches to probe protein-receptor interactions: focus on overcoming physiological barriersBinding, transcytosis and biodistribution of anti-PECAM-1 iron oxide nanoparticles for brain-targeted delivery.In vivo role of B lymphocytes in somatic transgene immunization.3D single molecule tracking with multifocal plane microscopy reveals rapid intercellular transferrin transport at epithelial cell barriers.Mass spectrometry-guided optimization and characterization of a biologically active transferrin-lysozyme model drug conjugate.Blood-brain barrier transport of therapeutics via receptor-mediationPharmacokinetics of recombinant bifunctional fusion proteins.Polymeric nanoparticles for the drug delivery to the central nervous system.Iron uptake and transport across physiological barriers.Receptor-mediated therapeutic transport across the blood-brain barrier.Potential of polymeric nanoparticles in AIDS treatment and prevention.Advances and challenges in developing cytokine fusion proteins as improved therapeutics.Developing therapeutic antibodies for neurodegenerative disease.Proteins: emerging carrier for delivery of cancer therapeutics.CNS drug targeting: have we travelled in right path?Immunotherapy for Alzheimer's disease: past, present and futureEmerging insights into barriers to effective brain tumor therapeutics.Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma.In vitro and initial in vivo evaluation of (68)Ga-labeled transferrin receptor (TfR) binding peptides as potential carriers for enhanced drug transport into TfR expressing cells.Applications of ApoB LDLR-Binding Domain Approach for the Development of CNS-Penetrating Peptides for Alzheimer's Disease.Targeting of drugs to cell surface receptors.A non-invasive system for delivering neural growth factors across the blood-brain barrier: a review.In vitro characterization of an acetylcholine receptor-transferrin fusion protein for the treatment of myasthenia gravis.Production and characterization of fusion proteins containing transferrin and nerve growth factor.Targeted Delivery of Protein Drugs by Nanocarriers.
P2860
Q28082016-AD811D70-0345-43A4-8150-4DB0B6745A0EQ30957737-C0E7B089-E9E6-4F25-AF9C-FFFAE4072134Q31119779-E78B210D-456F-4529-AA41-5ECA68D9B8B0Q31123144-790B523A-DEE5-41A0-AB2D-832AD7988CAEQ33625084-06E15C97-541F-481B-8481-710A323928A8Q34691652-293A0ACE-FB70-49EF-9F96-A72D187F282BQ35053858-FB4E47A3-01C2-4B35-9E76-3D67796C4363Q36184505-823A04E3-5363-42A9-8966-2A7086445B93Q36317924-B4C818A6-C335-4765-9AF5-6DA675493D49Q36824142-7D256F13-51AB-4953-A823-D6385FF98953Q36874295-7425C17E-BA00-46A9-88C2-8C38F68C90C1Q37033032-67996ADC-6968-4A96-9F08-06883DA730DBQ37076360-3B8DC020-E1DF-4D7E-B9F3-FE747834328DQ37150438-4635224B-E7B0-44C0-9C07-27D52C2A4202Q37773246-356A86A7-86B7-46DA-B160-F61F9437214CQ37818325-30912CC5-3BB5-4E3C-96F4-C64A3AB47DA7Q38088357-68412A9E-757D-449A-8AF5-7E87C8B1A837Q38095360-897BD82B-D642-4960-8315-8A7315F88F36Q38116070-D5E0F5FB-F429-4CF1-AD7E-F46A706103EDQ38127262-0B5BBDEB-0FEE-44DC-B8B4-19CAF00D634DQ38222750-DDFAABF8-1E04-4AD8-8D0C-7F2E92EF3F13Q38237653-3D414864-26C7-41AA-ACB2-7F732C3B7F46Q38998571-59B925E8-E864-472C-8164-70C28583F44CQ39703349-7A3EEB68-DD7F-44B8-86B5-090DBC37FBF1Q40706306-63E6686D-9D99-4BEE-A298-A89785F1F465Q41506607-19A705DA-4EA7-4F59-929F-66358622B6D5Q42458889-03F56782-BF98-4399-8909-7137C3CAA332Q43093968-492C3248-4F46-41DD-917A-A67E20268CD4Q48377810-49A54EA4-C3BD-41EC-9D0D-9E67B85D4766Q54647504-2568E7F4-8262-40C4-AFC6-702D0A485365
P2860
Transferrin-antibody fusion proteins are effective in brain targeting
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Transferrin-antibody fusion proteins are effective in brain targeting
@ast
Transferrin-antibody fusion proteins are effective in brain targeting
@en
Transferrin-antibody fusion proteins are effective in brain targeting
@nl
type
label
Transferrin-antibody fusion proteins are effective in brain targeting
@ast
Transferrin-antibody fusion proteins are effective in brain targeting
@en
Transferrin-antibody fusion proteins are effective in brain targeting
@nl
prefLabel
Transferrin-antibody fusion proteins are effective in brain targeting
@ast
Transferrin-antibody fusion proteins are effective in brain targeting
@en
Transferrin-antibody fusion proteins are effective in brain targeting
@nl
P2093
P2860
P356
P1476
Transferrin-antibody fusion proteins are effective in brain targeting
@en
P2093
P2860
P304
P356
10.1073/PNAS.92.7.2820
P407
P577
1995-03-01T00:00:00Z